Kunming Longjin Pharmaceutical Co Ltd (002750) — Cash Flow Reinvestment Rate
Kunming Longjin Pharmaceutical Co Ltd (002750) has a Cash Flow Reinvestment Rate of 146.78x as of December 2022, reinvesting CN¥127.33 Million (capex CN¥5.41 Million plus investments CN¥121.93 Million) from operating cash flow of CN¥867.54K. Explore 002750 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kunming Longjin Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2011–2019)
Historical reinvestment intensity for Kunming Longjin Pharmaceutical Co Ltd across 9 annual periods. Also explore Kunming Longjin Pharmaceutical Co Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Kunming Longjin Pharmaceutical Co Ltd (2011–2019)
Year-by-year capital reinvestment analysis for Kunming Longjin Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 002750 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 49.98x | CN¥202.07 Million | CN¥4.04 Million | CN¥7.07 Million | ▲ +399.9% |
| 2018 | 10.00x | CN¥316.91 Million | CN¥31.70 Million | CN¥15.53 Million | ▲ +1264.5% |
| 2017 | 0.73x | CN¥42.54 Million | CN¥58.06 Million | CN¥17.54 Million | ▼ -67.5% |
| 2016 | 2.25x | CN¥235.06 Million | CN¥104.24 Million | CN¥23.56 Million | ▼ -18.4% |
| 2015 | 2.76x | CN¥193.93 Million | CN¥70.19 Million | CN¥23.93 Million | ▲ +949.5% |
| 2014 | 0.26x | CN¥18.47 Million | CN¥70.16 Million | CN¥18.47 Million | ▼ -52.9% |
| 2013 | 0.56x | CN¥59.57 Million | CN¥106.46 Million | CN¥59.57 Million | ▼ -31.2% |
| 2012 | 0.81x | CN¥74.14 Million | CN¥91.16 Million | CN¥74.14 Million | ▼ -33.5% |
| 2011 | 1.22x | CN¥92.79 Million | CN¥75.90 Million | CN¥92.79 Million | — |